Related Experiment Video
Updated: Mar 21, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the
Wataru Nakajima1,2, Kanika Sharma1, June Young Lee1
1Phillips Institute for Oral Health Research, School of Dentistry, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
Abstract:
Noxa, a BH3-only pro-apoptotic BCL-2 family protein, causes apoptosis by specifically interacting with the anti-apoptotic protein MCL-1 to induce its proteasome-mediated degradation. We show here that the DNA damaging agents cisplatin and etoposide upregulate Noxa expression, which is required for the phosphorylation of MCL-1 at Ser64/Thr70 sites, proteasome-dependent degradation, and apoptosis. Noxa-induced MCL-1 phosphorylation at these sites occurs at the mitochondria and is primarily regulated by CDK2. MCL-1 and CDK2 form a stable complex and Noxa binds to this complex to facilitate the phosphorylation of MCL-1. When Ser64 and Thr70 of MCL-1 are substituted with alanine, the mutated MCL-1 is neither phosphorylated nor ubiquitinated, and becomes more stable than the wild-type protein. As a consequence, this mutant can inhibit apoptosis induced by Noxa overexpression or cisplatin treatment. These results indicate that Noxa-mediated MCL-1 phosphorylation followed by MCL-1 degradation is critical for apoptosis induced by DNA damaging agents through regulation of the Noxa/MCL-1/CDK2 complex.
Insights
The pro-apoptotic protein Noxa triggers cell death by targeting MCL-1 for degradation. DNA damaging agents induce Noxa, leading to MCL-1 phosphorylation and apoptosis via the Noxa/MCL-1/CDK2 complex.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Noxa is a BH3-only protein that induces apoptosis by interacting with anti-apoptotic BCL-2 family proteins.
- MCL-1 is an anti-apoptotic protein that plays a critical role in cell survival.
- DNA damaging agents can trigger apoptosis through various pathways.
Purpose of the Study:
- To elucidate the mechanism by which Noxa induces apoptosis.
- To investigate the role of MCL-1 phosphorylation in Noxa-mediated apoptosis.
- To identify the key regulators involved in the Noxa-MCL-1 interaction.
Main Methods:
- Western blotting to detect protein levels and phosphorylation.
- Immunoprecipitation to analyze protein complexes.
- Site-directed mutagenesis to study the function of specific phosphorylation sites.
- Cell viability assays to assess apoptosis.
Main Results:
- DNA damaging agents (cisplatin, etoposide) upregulate Noxa expression.
- Noxa is required for the phosphorylation of MCL-1 at Ser64/Thr70 sites, leading to its proteasome-mediated degradation and apoptosis.
- MCL-1 phosphorylation occurs at the mitochondria and is regulated by CDK2, forming a stable complex with MCL-1.
- Noxa binds to the MCL-1/CDK2 complex, facilitating MCL-1 phosphorylation.
- Mutating Ser64/Thr70 of MCL-1 to alanine renders it resistant to phosphorylation and degradation, inhibiting Noxa- or cisplatin-induced apoptosis.
Conclusions:
- Noxa-mediated phosphorylation of MCL-1 at Ser64/Thr70, followed by its degradation, is crucial for apoptosis induced by DNA damaging agents.
- The Noxa/MCL-1/CDK2 complex is a key regulatory hub in this apoptotic pathway.
- Targeting this complex may offer therapeutic strategies for cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
The Extrinsic Apoptotic Pathway
Abnormal Proliferation

